在社区获得性肺炎的重症患者中使用皮质类固醇:系统性审查和贝叶斯元分析
Wei Yu Chua1, Natalie Chew1, Shruthi C Iyer1
1Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Annals of the Academy of Medicine, Singapore
|December 5, 2024
概括
系统性皮质类固醇并没有显著降低重症监护病房的细菌社区获得性肺炎患者的死亡率. 然而,它们确实减少了对机械通风的需求,而皮特别降低了医院死亡率.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 社区获得的细菌性肺炎 (CAP) 是重症监护室 (ICU) 中死亡的重要原因.
- 系统性皮质类固醇作为严重CAP的辅助治疗的作用仍在争论中.
研究的目的:
- 系统地审查和元分析随机对照试验 (RCT),评估ICU细菌CAP患者系统性皮质类固醇的有效性和安全性.
- 评估皮质类固醇对死亡率,机械通风和不良事件的影响.
主要方法:
- 在MEDLINE,Embase和Cochrane图书馆进行了全面的搜索,截至2024年2月.
- 对涉及1585名患者的6项RCT的贝叶斯元分析是按照PRISMA指南进行的.
- 数据提取和偏差风险评估由两个审稿人独立进行.
主要成果:
- 系统性皮质类固醇并没有显著降低ICU患者严重CAP (证据确定性低) 的住院或全因死亡率.
- 皮质类固醇使用显著减少了机械通风的需要 (证据的高度确定性).
- 一项小组分析显示,皮质显著降低了医院死亡率 (证据确定性低).
结论:
- 系统性皮质类固醇显著降低了细菌CAP的ICU患者的机械通风需求.
- 皮证明了医院死亡率的显著降低.
- 需要进一步的研究,以澄清其他皮质类固醇在这种患者群体中的死亡率益处.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
178
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
178
01:30Pneumonia III: Complications and Assessment
165
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
165
01:28Pneumonia IV: Management
299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299
01:29Pneumonia II: Pathophysiology
216
The pathophysiology of pneumonia involves the following steps:
216
01:30Pneumonia V: Nursing management and Prevention
1.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.9K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K